Physician profile
Benjamin Gier
NPI 1437528478
$5,077.02
in general payments reported to CMS, 2019-2025
18 companies · $2,047 in 2025
The $2,047 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.40 · 2022: $173 · 2023: $1,568 · 2024: $1,274 · 2025: $2,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,744 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,744.18 |
| Education | $145.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,192.57 | 2022-2025 | |
| Janssen Biotech, INC. | $849.67 | 2023-2025 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $401.54 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $319.81 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $283.65 | 2023-2025 | Aklief, Twyneo, Nemluvio |
| Lilly USA, LLC | $271.62 | 2024-2025 | Ebglyss, Taltz |
| Amgen INC. | $267.96 | 2023-2025 | Otezla, Otezla |
| Organon LLC | $221.07 | 2024-2025 | Vtama |
| Genzyme Corporation | $221.05 | 2023-2025 | |
| Dermavant Sciences, INC. | $214.49 | 2024 | Vtama |
| Ucb, INC. | $194.56 | 2023-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $187.05 | 2022-2025 | Winlevi, Ilumya |
| Arcutis Biotherapeutics, INC. | $126.16 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $119.31 | 2024-2025 | Cabtreo |
| Regeneron Healthcare Solutions, INC. | $107.99 | 2023-2024 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.76 | 2023-2025 | Cyltezo, Spevigo |
| Incyte Corporation | $18.36 | 2023 | Opzelura |
| Medtronic, INC. | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Gier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.